Medtronic Stock Forecast, Price & News

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 5 hold ratings, 16 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic or view top-rated stocks.

Wall Street analysts have given Medtronic a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medtronic wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, November 23rd 2021.
View our earnings forecast for Medtronic.

Medtronic plc (NYSE:MDT) issued its quarterly earnings data on Monday, August, 23rd. The medical technology company reported $1.41 EPS for the quarter, topping the Zacks' consensus estimate of $1.32 by $0.09. The medical technology company earned $7.99 billion during the quarter, compared to analyst estimates of $7.88 billion. Medtronic had a net margin of 12.29% and a trailing twelve-month return on equity of 13.85%. Medtronic's revenue for the quarter was up 22.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.62 earnings per share.
View Medtronic's earnings history.

Medtronic's stock was trading at $92.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MDT shares have increased by 38.3% and is now trading at $127.84.
View which stocks have been most impacted by COVID-19.

Medtronic declared a quarterly dividend on Monday, August 23rd. Stockholders of record on Friday, September 24th will be given a dividend of $0.63 per share on Friday, October 15th. This represents a $2.52 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date is Thursday, September 23rd.
View Medtronic's dividend history.

Medtronic pays an annual dividend of $2.52 per share and currently has a dividend yield of 1.96%.
View Medtronic's dividend history.

Medtronic updated its FY 2022 earnings guidance on Tuesday, September, 21st. The company provided earnings per share guidance of $5.650-$5.750 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.690. The company issued revenue guidance of -.

22 analysts have issued 1 year price objectives for Medtronic's stock. Their forecasts range from $119.00 to $165.00. On average, they expect Medtronic's share price to reach $144.24 in the next twelve months. This suggests a possible upside of 12.8% from the stock's current price.
View analysts' price targets for Medtronic or view top-rated stocks among Wall Street analysts.

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Baxter International (BAX), STERIS (STE), Insulet (PODD), Hologic (HOLX), Teleflex (TFX) and Abiomed (ABMD).
View all of MDT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), The Home Depot (HD) and Walmart (WMT).

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.32%), BlackRock Inc. (7.78%), State Street Corp (4.16%), Massachusetts Financial Services Co. MA (3.43%), Lazard Asset Management LLC (1.83%) and Price T Rowe Associates Inc. MD (1.69%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz, Robert John White and Sean Salmon.
View institutional ownership trends for Medtronic.

MDT stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Boston Partners, BlackRock Inc., Massachusetts Financial Services Co. MA, Franklin Resources Inc., Barrow Hanley Mewhinney & Strauss LLC, Carmignac Gestion, and Wells Fargo & Company MN. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Omar Ishrak, Robert John White, and Sean Salmon.
View insider buying and selling activity for Medtronic or view top insider-selling stocks.

MDT stock was acquired by a variety of institutional investors in the last quarter, including Amundi, Jefferies Group LLC, Sanders Capital LLC, Invesco Ltd., Prospera Financial Services Inc, Canada Pension Plan Investment Board, FMR LLC, and State Street Corp. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic or or view top insider-buying stocks.

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDT stock can currently be purchased for approximately $127.84.

Medtronic has a market capitalization of $171.80 billion and generates $30.12 billion in revenue each year.

Medtronic employs 90,000 workers across the globe.

Medtronic was founded in 1949.

The official website for Medtronic is www.medtronic.com.

Medtronic is headquartered at 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at (531) 438-1700 or via email at [email protected].